Category: Business Culture
Homeostatic Vectors in Business Model Innovation
Homeostatic vectors (or mechanisms) represent a common challenge for internal stakeholders championing business model innovation. The purpose of the former often supersedes and contradicts that intention of the latter. Homeostatic...
The Mental Model in Complex Business Systems
The role of your company’s mental model for competition is to offer a framework through which complex data, observation, and inferences can be interpreted. The power of each explanatory model...
Business Competition Myths: Fact & Fiction
Competitive advantage, or business competition, is often treated as a myth. This is clear when either a ‘seat of the pants’ approach is taken to corporate governance and strategy or...
Systems Thinking in Leadership Innovation
Systems thinking advanced on earlier models of thought about how structures interact and how to influence them. Historical leaders models have been criticized for being overly linear and deterministic. Unable...
SWOT Analysis in Business Model Innovation
SWOT assessment involves identifying the relative strengths, weaknesses, opportunities, and threats of the business model. This includes the regulatory, economic, political, social, and internal environments. Delineating fact from fiction, preference...
Supply Chain Management Vectors in Innovation
Article Content Supply Chain Management Outsourcing Product Supply Chain Digital Services Supply Chain Expertise, Quality, Location, Value, & Organization – Characteristics Supply Chain Innovation Opportunities Supply Chain Innovation Planning Tool...
Leadership Model Vacuum: Serving with Purpose & Intent
The path to developing an effective leadership model is as varied as the definitions often adopted in the business sector. The context in which leadership is being defined strongly determines...
Data Analytics: A Business Case of Innovation
The demands on the Pharmaceutical & Healthcare Industries to support innovation are at its peak. Healthcare legislation is being actively challenged and profit margins (and operating revenue) for the pharmaceutical...